Drupal.behaviors.print = function(context) {window.print();window.close();}>
FDA Grants Second Authorization for Focus Diagnostics' H1N1 Flu Test
October 19, 2009
FDA Grants Second Authorization for Focus Diagnostics' H1N1 Flu Test
By a GenomeWeb staff reporter
The newest authorization allows testing on 3M's molecular diagnostic system.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
3M Ships First Thermal Cycler in Partnership with Quest; Firms Eye Hospital Lab Market for Compact System
October 26, 2009 / GenomeWeb Daily News
BioFire, Focus, IQuum Share $23.1M to Develop Platform, Assays for Biological Warfare Agent Detection
February 12, 2013 / GenomeWeb Daily News
FDA Clears Focus Diagnostics' Flu Test on 3M Integrated Cycler
October 9, 2012 / GenomeWeb Daily News
FDA Clears Quest's C. difficile Molecular Test
April 11, 2012 / GenomeWeb Daily News
Quest Gets Brazilian OK for Dengue MDx Test
December 6, 2011 / GenomeWeb Daily News